ArticleCancers2022

The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers.

Jean-Christophe Currie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.